Almasan AG
  • Landing
  • Home
  • About
  • Portfolio
  • Services
  • Insights
  • Contact
  • Cookie Policy (EU)
Select Page

Contract Research – Deriving Strategic Value from Emerging Markets

by Aleksandar Ruzicic | Jun 20, 2024 | R&D and Innovation Management

Globally pharmaceutical companies are under immense pressure, with existing lobally pharmaceutical business models under threat. The growth is expected to taper off in the US and other developed countries, while emerging economies are expected to drive a large part of...

Potential to grow: A true understanding of the challenges of niche markets is needed for companies to achieve worthwile returns

by Aleksandar Ruzicic | Jun 11, 2024 | Business Optimization

For a long time, the pharmaceutical industry was not required to prove superior outcomes to generate large surpluses: companies were paid above the amount required to sustain the economic viability of their product portfolio. Today, severe pressure on healthcare...

Introduction of SwissDRG – upheavals in hospital purchasing require… …new strategies for medical technology providers

by Aleksandar Ruzicic | Jun 5, 2024 | Healthcare

Thanks to its international experience, the Swiss medical technology sector is well aware of the latest developments in the healthcare market, especially as smaller companies also tend to work the European markets bordering Switzerland intensively and directly. In the...

If the shoe fits: Pharma needs to put its best foot forward and use the range of tactical responses at its disposal to meet payers’ demands

by Aleksandar Ruzicic | May 27, 2024 | Business Optimization

Despite what we are asked to believe, pharmaceutical marketers used to have it easy. Marketing predominantly to doctors, companies positioned their patent protected drug against competitive products, seeking any meaningful differentiation to drive market share (or...

SwissDRG – opportunities and risks for Swiss hospitals

by Aleksandar Ruzicic | May 22, 2024 | Healthcare

The SwissDRG remuneration system is intended to take account of the varying degrees of severity of individual diagnoses and procedures. However, the remuneration system does not take into account the respective cost structures and expenses of the hospital for a...
« Older Entries
Next Entries »
    Website built by The Free Website Guys🚀
    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    • Manage options
    • Manage services
    • Manage {vendor_count} vendors
    • Read more about these purposes
    View preferences
    • {title}
    • {title}
    • {title}